Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher Bristow
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/P53 Mutant Lung Cancer
Cancers
Cancer Research
Oncology
Related publications
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
Frontiers in Oncology
Cancer Research
Oncology
Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Checkpoint Blockade Therapy Resistance in Hodgkin's Lymphoma
The Lancet
Medicine
A Novel Mutant P53 Binding Partner BAG5 Stabilizes Mutant P53 and Promotes Mutant P53 GOFs in Tumorigenesis
Cell Discovery
Biochemistry
Genetics
Cell Biology
Molecular Biology